UCB SA header image

UCB SA

UCB

Equity

ISIN BE0003739530 / Valor 986410

Euronext - Euronext Brussels (2026-05-05)

EUR 231.00+1.09%

UCB SA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

UCB SA is a global biopharmaceutical company focused on the research, development, and commercialization of innovative therapies for severe diseases, particularly in the areas of neurology and immunology. Through its investment division, UCB Ventures, the company supports pioneering startups and technologies that aim to improve the lives of individuals affected by challenging health conditions. By leveraging its expertise and resources, UCB SA strives to address unmet medical needs and deliver impactful medical solutions to patients worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

36.1%1Y

180%3Y

203%5Y

Performance

37.4%1Y

30.4%3Y

28.5%5Y

Volatility

51756 M

Market cap (USD)

188,342

Daily traded volume (Shares)

192.15 / 187.65

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc Valor: 1806798

Annual Return

-50%0%+50%

Risk level

110

1.07%USD 301.11

BeiGene Ltd

BeiGene Ltd Valor: 30165310

Annual Return

-50%0%+50%

Risk level

110

0.12%USD 297.49

Align Technology Inc

Align Technology Inc Valor: 1159441

Annual Return

-50%0%+50%

Risk level

110

-1.84%USD 168.71

Icon PLC

Icon PLC Valor: 1017575

Annual Return

-50%0%+50%

Risk level

110

8.35%USD 121.32

Royalty Pharma PLC

Royalty Pharma PLC Valor: 55041695

Annual Return

-50%0%+50%

Risk level

110

0.48%USD 50.44

Viatris Inc

Viatris Inc Valor: 58198423

Annual Return

-50%0%+50%

Risk level

110

2.11%USD 15.52

Bristol-Myers Squibb Co

Bristol-Myers Squibb Co Valor: 914188

Annual Return

-50%0%+50%

Risk level

110

-0.75%USD 56.95

Alignment Healthcare Inc

Alignment Healthcare Inc Valor: 110387702

Annual Return

-50%0%+50%

Risk level

110

-4.98%USD 18.30

Bruker Corp

Bruker Corp Valor: 1635622

Annual Return

-50%0%+50%

Risk level

110

4.45%USD 38.01

Masimo Corp

Masimo Corp Valor: 493578

Annual Return

-50%0%+50%

Risk level

110

0.21%USD 178.58

SIX

FactSet

Clearbit

Logos provided by Clearbit